Concepedia

Ying‐Chu Chen

YC

4

Publications

110

Citations

4

H-Index

2016

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

Ying‐Chu Chen is an author at AstraZeneca (United Kingdom) specializing in drug discovery, medicine, and signal transduction.

Top concepts

Publications per year

2016–2018

4

Publications

4

Covalent Modulators of the Vacuolar ATPase

Ying‐Chu Chen, Keriann M. Backus, Maria Merkulova et al. · Journal of the American Chemical Society · 2016 · 41 citations · Full text

Development of Specific, Irreversible Inhibitors for a Receptor Tyrosine Kinase EphB3

Alvin Kung, Ying‐Chu Chen, Marianne Schimpl et al. · Journal of the American Chemical Society · 2016 · 36 citations · Full text

, , +20

A Chemical-Genetic Approach to Generate Selective Covalent Inhibitors of Protein Kinases

Alvin Kung, Marianne Schimpl, Arunika I. Ekanayake et al. · ACS Chemical Biology · 2017 · 20 citations · Full text

, , +17

Effects of rigidity on the selectivity of protein kinase inhibitors

Amir Assadieskandar, C. Yu, Pierre Maisonneuve et al. · European Journal of Medicinal Chemistry · 2018 · 13 citations · Full text

, , +8

Rows per page

1–4 of 4